Analysis of Vital Signs in Patients With COVID-19
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Respiratory Disease
- Sponsor
- Oxehealth Limited
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Breathing rates
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.
Detailed Description
The investigators will analyse data from patients with known COVID 19 infection both during, and where possible before clinical COVID 19 infection and controls to determine whether changes can be detected in these parameters that precede overt clinical deterioration. The role of remote vision-based patient monitoring and management in supporting the care of patients with COVID-19 will be assessed through staff interviews.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients age 18 and above. Patients on wards with a medical diagnosis of COVID 19 who are in rooms with the Vision based patient monitoring and management system.
Exclusion Criteria
- •Children will be excluded. No data will be excluded unless specifically requested by the treating clinician.
Outcomes
Primary Outcomes
Breathing rates
Time Frame: Data will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19.
Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.
Secondary Outcomes
- BR and PR(Data will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19.)
- Pulse rates(Data will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19.)